跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Grastiwell - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Grastiwell
Approved
STANDARD
Grastiwell
Reliance Life Sciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c08f7e5af3a126bb
Company
Reliance Life Sciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c08f7e5af3a126bb
Drug Approval Philippines Name
Grastiwell
Product Name
Grastiwell
Registration Number
BRP-051-02
Brand Name
Grastiwell
Generic Name
Filgrastim
Dosage Form
Solution For Injection (Iv/Sc)
Dosage Strength
300 mcg/ 0.5 mL
Manufacturer
Reliance Life Sciences Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Detoxicare Philippines, Inc
Issuance Date
25 March 2024
Expiry Date
07 August 2029
Pharmacologic Category
Colony Stimulating Factor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c08f7e5af3a126bb
Type
Standard
Back to Philippines FDA Approvals